Back HCV Treatment Drug Advisories & Warnings

FDA Warns of Heart Risk When Combining Amiodarone with Sovaldi or Harvoni

The new oral hepatitis C drug sofosbuvir, either in the sofosbuvir/ ledipasvir coformulation (Harvoni) or with other direct-acting antivirals, should not be taken with the anti-arrhythmic medication amiodarone, the U.S. Food and Drug Association (FDA) and Gilead Sciences warned after several patients developed decreased heart rate (bradycardia) and 1 had a fatal heart attack when they combined these drugs.

alt

Read more: